Oral NNMT inhibitor studied for metabolism and fat cells.

An older oral SARM researched for lean tissue, noted for a temporary, reversible vision side effect.

Modified GH fragment studied for fat metabolism.

Studied for nerve repair and neuropathic discomfort.

Studied for gut, tendon, and soft-tissue repair.

Long-acting amylin analog studied for satiety and weight loss.

An oral PPAR-delta agonist (it switches on a receptor that controls how you burn fuel), often grouped with SARMs, studied for endurance and fat metabolism.

Neurotrophic peptide mix studied for brain recovery.

Long-acting GHRH analog that raises baseline GH.

Growth-hormone secretagogue combo (it nudges your body to release its own growth hormone).

Very potent peptide studied for synapse formation.

Tetrapeptide studied for telomeres and sleep rhythm.

Myostatin-inhibiting peptide studied for muscle growth.

Copper peptide studied for skin, hair, and tissue remodeling.

Growth-hormone releasing peptide with a strong pulse.

GH releasing peptide known for strong hunger signaling.

Potent GH releasing peptide; desensitizes with overuse.

Growth-hormone fragment studied for targeted fat loss.

Mitochondrial-derived peptide studied for cell protection.

Short-acting IGF-1 variant for localized muscle effect.

Long-acting IGF-1 analog studied for muscle growth.

Clean, selective growth-hormone pulse with few side effects.

Upstream hormone peptide studied for libido and fertility.

Anti-inflammatory tripeptide studied for gut and skin.

An oral SARM researched for lean tissue and strength.

GLP-1 agonist (it acts like the gut hormone that curbs hunger), an earlier generation of the class.

Antimicrobial peptide studied for innate immunity.

Tanning peptide studied for pigment and photoprotection.

Tanning peptide with appetite and libido effects.

Oral growth-hormone secretagogue (it nudges your body to release its own growth hormone).

Mitochondrial peptide studied for metabolism and endurance.

Coenzyme studied for cellular energy and longevity.

A widely studied oral SARM, researched for lean tissue and physical function.

Mechano growth factor studied for muscle repair.

Newer stable peptide studied as a BPC-157 alternative.

Bremelanotide, studied for libido and arousal.

A potent oral SARM researched for strong androgen-receptor signaling.

Triple-receptor GLP-1 agonist (it switches on three fat-loss receptors at once), studied for significant fat loss.

Calming nootropic peptide studied for anxiety and focus.

GLP-1 agonist (it acts like the gut hormone that curbs hunger), the original mainstream weight-loss peptide.

Nootropic peptide studied for focus and neuroprotection.

Classic GHRH analog studied for sleep and recovery.

Mitochondria-targeted peptide studied for cellular energy.

GLP-1/glucagon dual agonist (it switches on two metabolism receptors), studied for weight and liver health.

Thymosin beta-4 fragment, studied for recovery and mobility.

GHRH analog studied for visceral (belly) fat reduction.

Prescription testosterone replacement therapy, injected into muscle and monitored by a clinician.

Thymus peptide studied for immune regulation and aging.

Immune-modulating peptide studied for resilience.

Dual GIP/GLP-1 agonist (it switches on two appetite receptors) for appetite control and fat loss.

Vasoactive intestinal peptide studied for inflammation.

A research compound often grouped with SARMs, studied for myostatin-related pathways, with very limited data.